TARELLA, Corrado
TARELLA, Corrado
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
A phase I-II multicenter study on G-CSF in ALS: clinical and hematological results
2009-01-01 Moglia C; Calvo A; Mora G; Caponnetto C; Siciliano G; Sabatelli M; La Bella V; Silani V; Corbo M; Mancardi GL; Tonali PA; Mutani R; Tarella C; Chio' A
A pilot trial of G-CSF in amyotrophic lateral sclerosis
2008-01-01 Chio' A; Mora G; Caponnetto C; Siciliano G; Sabatelli M; La Bella V; Silani V; Moglia C; Mancardi GL; Tonali P; Calvo A; Mutani R; Corbo M; Scime’ R; D’Onofrio G; Petrini M; Melazzini M. Gualandi F; Tarella C
A short course of granulocyte-colony-stimulating factor to accelerate wound repair in patients undergoing surgery for sacrococcygeal pilonidal cyst: proof of concept
2012-01-01 C.M. FRONTICELLI BALDELLI; M. RUELLA; S. SCUDERI; M. MONNI; R. PASSERA; P. OMEDE; C. TARELLA
A single step density gradient separation for large scale enrichment of mobilized peripheral blood progenitor cells collected for autotransplantation.
1998-01-01 FERRERO D ;TARELLA C ;CHERASCO C ;BONDESAN P ;OMEDÈ P ;RAVAGLIA R ;CARACCIOLO D ;CASTELLINO C ;PILERI A
A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients.
2001-01-01 M. LADETTO; SAMETTI S; DONOVAN JW; FERRERO D; ASTOLFI M; MITTERER M; RICCA I; DRANDI D; CORRADINI P; COSER P; PILERI A; GRIBBEN JG; TARELLA C.
Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups.
2013-01-01 Riva L; Ronchini C; Bodini M; Lo-Coco F; Lavorgna S; Ottone T; Martinelli G; Iacobucci I; Tarella C; Cignetti A; Volorio S; Bernard L; Russo A; Melloni GE; Luzi L; Alcalay M; Dellino GI; Pelicci PG
Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: Results of a multicenter study
2016-01-01 Ruella, Marco; Filippi, Andrea Riccardo; Bruna, Riccardo; Di Russo, Anna; Magni, Michele; Caracciolo, Daniele; Passera, Roberto; Matteucci, Paola; Di Nicola, Massimo; Corradini, Paolo; Parvis, Guido; Gini, Guido; Olivieri, Attilio; Ladetto, Marco; Ricardi, Umberto; Tarella, Corrado; Devizzi, Liliana
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial
2007-01-01 GALLAMINI A; ZAJA F; PATTI C; BILLIO A; SPECCHIA MR; TUCCI A; LEVIS A; MANNA A; SECONDO V; RIGACCI L; PINTO A; IANNITTO E; ZOLI V; TORCHIO P; PILERI S; TARELLA C
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome
2007-01-01 CORRADINI P; DODERO A; FARINA L; FANIN R; PATRIARCA F; MICELI R; MATTEUCCI P; BREGNI M; SCIMÈ R; NARNI F; POGLIANI E; LOCASCIULLI A; MILANI R; CARNITI C; BACIGALUPO A; RAMBALDI A; BONIFAZI F; OLIVIERI A; GIANNI AM; TARELLA C
Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myeloma.
1998-01-01 Majolino I; Corradini P; Scimè R; Santoro A; Tarella C; Cavallaro AM; Palumbo A; Indovina A; Caracciolo D; Boccadoro M; Marcenò R; Pileri A.
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy.
1999-01-01 Boccadoro M; Tarella C; Palumbo A; Argentino C; Triolo S; Dominietto A; Callea V; Lauta VM; Molica S; Musto P; Marmont F; Gianni AM; Pileri A
Analysis of the immunoglobulin heavy-chain gene rearrangement providing molecular evidence of second lymphoma in a patient in apparent relapse after autotransplantation.
1997-01-01 Campana S; Corradini P; Astolfi M; Ladetto M; Cinque F; Novero D; Tarella C; Pileri A.
Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disorders.
1986-01-01 Ferrero D; Tarella C; Pregno P; Pileri A; Gallo E.
Autologous bone marrow transplantation in acute myeloid leukemia after in-vitro purging with an anti-lacto-N-fucopentaose III antibody and rabbit complement.
1987-01-01 Ferrero D; De Fabritiis P; Amadori S; De Felice L; Gallo E; Meloni G; Pregno P; Pulsoni A; Simone F; Tarella C; Pileri A; Rovera G; Mandelli F
Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial.
2013-01-01 125. Zimmermann H; Choquet S; Moore J; Salles G; Morschhauser F; Lamy T; Jaccard A; Horst HA; Leithäuser M; Dührsen U; Reinke P; Lebranchu Y; Neuhaus R; Lehmkuhl H; Tarella C; Schlattmann P; Riess H; Leblond V.
Bone marrow transplantation for lymphoma CR1
2005-01-01 TARELLA C; GIANNI AM
Bone marrow-derived cell mobilization by G-CSF to enhance osseointegration of bone substitute in high tibial osteotomy.
2013-01-01 Marmotti A; Castoldi F; Rossi R; Marenco S; Risso A; Ruella M; Tron A; Borrè A; Blonna D; Tarella C.
Both early and committed progenitors are more frequent in peripheral blood than in bone marrow during mobilization induced by high-dose chemotherapy + G-CSF.
1995-01-01 C. TARELLA; BENEDETTI G; CARACCIOLO D; CASTELLINO C; CHERASCO C; BONDESAN P; OMEDE' P; RUGGIERI D; GIANNI AM; PILERI A
CD34-positive cells: biology and clinical relevance.
1995-01-01 CARLO-STELLA C; CAZZOLA M; DE FABRITIIS P; DE VINCENTIIS A; GIANNI AM; LANZA F; LAURIA F; LEMOLI RM; C. TARELLA; ZANON P; TURA S.
Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations
2006-01-01 LADETTO M; MANTOAN B; DE MARCO F; DRANDI D; AGUZZI C; ASTOLFI M; VALLET S; RICCA I; AQUILA MD; PAGLIANO G; MONITILLO L; POLLIO B; SANTO L; CRISTIANO C; ROCCI A; FRANCESE R; BODONI CL; BORCHIELLINI A; SCHINCO P; BOCCADORO M; TARELLA C
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A phase I-II multicenter study on G-CSF in ALS: clinical and hematological results | 2009 | Moglia C; Calvo A; Mora G; Caponnetto C; Siciliano G; Sabatelli M; La Bella V; Silani V; Corbo M; Mancardi GL; Tonali PA; Mutani R; Tarella C; Chio' A | |
| A pilot trial of G-CSF in amyotrophic lateral sclerosis | 2008 | Chio' A; Mora G; Caponnetto C; Siciliano G; Sabatelli M; La Bella V; Silani V; Moglia C; Mancardi GL; Tonali P; Calvo A; Mutani R; Corbo M; Scime’ R; D’Onofrio G; Petrini M; Melazzini M. Gualandi F; Tarella C | |
| A short course of granulocyte-colony-stimulating factor to accelerate wound repair in patients undergoing surgery for sacrococcygeal pilonidal cyst: proof of concept | 2012 | C.M. FRONTICELLI BALDELLI; M. RUELLA; S. SCUDERI; M. MONNI; R. PASSERA; P. OMEDE; C. TARELLA | |
| A single step density gradient separation for large scale enrichment of mobilized peripheral blood progenitor cells collected for autotransplantation. | 1998 | FERRERO D ;TARELLA C ;CHERASCO C ;BONDESAN P ;OMEDÈ P ;RAVAGLIA R ;CARACCIOLO D ;CASTELLINO C ;PILERI A | |
| A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients. | 2001 | M. LADETTO; SAMETTI S; DONOVAN JW; FERRERO D; ASTOLFI M; MITTERER M; RICCA I; DRANDI D; CORRADINI P; COSER P; PILERI A; GRIBBEN JG; TARELLA C. | |
| Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups. | 2013 | Riva L; Ronchini C; Bodini M; Lo-Coco F; Lavorgna S; Ottone T; Martinelli G; Iacobucci I; Tarella C; Cignetti A; Volorio S; Bernard L; Russo A; Melloni GE; Luzi L; Alcalay M; Dellino GI; Pelicci PG | |
| Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: Results of a multicenter study | 2016 | Ruella, Marco; Filippi, Andrea Riccardo; Bruna, Riccardo; Di Russo, Anna; Magni, Michele; Caracciolo, Daniele; Passera, Roberto; Matteucci, Paola; Di Nicola, Massimo; Corradini, Paolo; Parvis, Guido; Gini, Guido; Olivieri, Attilio; Ladetto, Marco; Ricardi, Umberto; Tarella, Corrado; Devizzi, Liliana | |
| Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial | 2007 | GALLAMINI A; ZAJA F; PATTI C; BILLIO A; SPECCHIA MR; TUCCI A; LEVIS A; MANNA A; SECONDO V; RIGACCI L; PINTO A; IANNITTO E; ZOLI V; TORCHIO P; PILERI S; TARELLA C | |
| Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome | 2007 | CORRADINI P; DODERO A; FARINA L; FANIN R; PATRIARCA F; MICELI R; MATTEUCCI P; BREGNI M; SCIMÈ R; NARNI F; POGLIANI E; LOCASCIULLI A; MILANI R; CARNITI C; BACIGALUPO A; RAMBALDI A; BONIFAZI F; OLIVIERI A; GIANNI AM; TARELLA C | |
| Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myeloma. | 1998 | Majolino I; Corradini P; Scimè R; Santoro A; Tarella C; Cavallaro AM; Palumbo A; Indovina A; Caracciolo D; Boccadoro M; Marcenò R; Pileri A. | |
| An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy. | 1999 | Boccadoro M; Tarella C; Palumbo A; Argentino C; Triolo S; Dominietto A; Callea V; Lauta VM; Molica S; Musto P; Marmont F; Gianni AM; Pileri A | |
| Analysis of the immunoglobulin heavy-chain gene rearrangement providing molecular evidence of second lymphoma in a patient in apparent relapse after autotransplantation. | 1997 | Campana S; Corradini P; Astolfi M; Ladetto M; Cinque F; Novero D; Tarella C; Pileri A. | |
| Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disorders. | 1986 | Ferrero D; Tarella C; Pregno P; Pileri A; Gallo E. | |
| Autologous bone marrow transplantation in acute myeloid leukemia after in-vitro purging with an anti-lacto-N-fucopentaose III antibody and rabbit complement. | 1987 | Ferrero D; De Fabritiis P; Amadori S; De Felice L; Gallo E; Meloni G; Pregno P; Pulsoni A; Simone F; Tarella C; Pileri A; Rovera G; Mandelli F | |
| Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial. | 2013 | 125. Zimmermann H; Choquet S; Moore J; Salles G; Morschhauser F; Lamy T; Jaccard A; Horst HA; Leithäuser M; Dührsen U; Reinke P; Lebranchu Y; Neuhaus R; Lehmkuhl H; Tarella C; Schlattmann P; Riess H; Leblond V. | |
| Bone marrow transplantation for lymphoma CR1 | 2005 | TARELLA C; GIANNI AM | |
| Bone marrow-derived cell mobilization by G-CSF to enhance osseointegration of bone substitute in high tibial osteotomy. | 2013 | Marmotti A; Castoldi F; Rossi R; Marenco S; Risso A; Ruella M; Tron A; Borrè A; Blonna D; Tarella C. | |
| Both early and committed progenitors are more frequent in peripheral blood than in bone marrow during mobilization induced by high-dose chemotherapy + G-CSF. | 1995 | C. TARELLA; BENEDETTI G; CARACCIOLO D; CASTELLINO C; CHERASCO C; BONDESAN P; OMEDE' P; RUGGIERI D; GIANNI AM; PILERI A | |
| CD34-positive cells: biology and clinical relevance. | 1995 | CARLO-STELLA C; CAZZOLA M; DE FABRITIIS P; DE VINCENTIIS A; GIANNI AM; LANZA F; LAURIA F; LEMOLI RM; C. TARELLA; ZANON P; TURA S. | |
| Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations | 2006 | LADETTO M; MANTOAN B; DE MARCO F; DRANDI D; AGUZZI C; ASTOLFI M; VALLET S; RICCA I; AQUILA MD; PAGLIANO G; MONITILLO L; POLLIO B; SANTO L; CRISTIANO C; ROCCI A; FRANCESE R; BODONI CL; BORCHIELLINI A; SCHINCO P; BOCCADORO M; TARELLA C |